LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 12

Search options

  1. Article ; Online: The effect of COVID-19 on parathyroid glands.

    Abobaker, Anis / Alzwi, Aboubaker

    Journal of infection and public health

    2021  Volume 14, Issue 6, Page(s) 724–725

    MeSH term(s) COVID-19 ; Humans ; Parathyroid Glands/diagnostic imaging ; SARS-CoV-2
    Language English
    Publishing date 2021-04-12
    Publishing country England
    Document type Letter
    ISSN 1876-035X
    ISSN (online) 1876-035X
    DOI 10.1016/j.jiph.2021.04.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The Eye: A Possible New Route of Infection in COVID-19.

    Abobaker, Anis / Alzwi, Aboubaker

    Disaster medicine and public health preparedness

    2020  Volume 14, Issue 4, Page(s) e25–e26

    MeSH term(s) COVID-19/epidemiology ; COVID-19/transmission ; Eye/physiopathology ; Humans ; Infection Control/instrumentation ; Infection Control/methods ; Infectious Disease Transmission, Patient-to-Professional/statistics & numerical data ; Nasolacrimal Duct/physiopathology ; Occupational Exposure ; Pandemics/prevention & control ; Personal Protective Equipment/standards ; Personal Protective Equipment/trends
    Keywords covid19
    Language English
    Publishing date 2020-07-27
    Publishing country United States
    Document type Letter
    ZDB-ID 2375268-3
    ISSN 1938-744X ; 1935-7893
    ISSN (online) 1938-744X
    ISSN 1935-7893
    DOI 10.1017/dmp.2020.270
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The Eye

    Abobaker, Anis / Alzwi, Aboubaker

    Disaster Medicine and Public Health Preparedness

    A Possible New Route of Infection in COVID-19

    2020  , Page(s) 1–2

    Keywords Public Health, Environmental and Occupational Health ; covid19
    Language English
    Publisher Cambridge University Press (CUP)
    Publishing country uk
    Document type Article ; Online
    ZDB-ID 2375268-3
    ISSN 1938-744X ; 1935-7893
    ISSN (online) 1938-744X
    ISSN 1935-7893
    DOI 10.1017/dmp.2020.270
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19.

    Gargouri, Mohamed / Alzwi, Aboubaker / Abobaker, Anis

    Medical hypotheses

    2020  Volume 146, Page(s) 110380

    MeSH term(s) COVID-19/drug therapy ; COVID-19/enzymology ; Cell Cycle/drug effects ; Cell Division/drug effects ; Cyclin-Dependent Kinases/antagonists & inhibitors ; Humans ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; SARS-CoV-2/drug effects ; SARS-CoV-2/physiology ; Virus Replication/drug effects
    Chemical Substances Protein Kinase Inhibitors ; Cyclin-Dependent Kinases (EC 2.7.11.22)
    Keywords covid19
    Language English
    Publishing date 2020-11-08
    Publishing country United States
    Document type Letter
    ZDB-ID 193145-3
    ISSN 1532-2777 ; 0306-9877
    ISSN (online) 1532-2777
    ISSN 0306-9877
    DOI 10.1016/j.mehy.2020.110380
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Overview of the possible role of vitamin C in management of COVID-19.

    Abobaker, Anis / Alzwi, Aboubaker / Alraied, Alsalheen Hamed A

    Pharmacological reports : PR

    2020  Volume 72, Issue 6, Page(s) 1517–1528

    Abstract: The mainstay of management of coronavirus disease 2019 (COVID-19) is mainly supportive as to date there is no effective antiviral treatment, apart from remdesivir which has been approved by Food and Drug administration (FDA) for treatment of COVID-19, or ...

    Abstract The mainstay of management of coronavirus disease 2019 (COVID-19) is mainly supportive as to date there is no effective antiviral treatment, apart from remdesivir which has been approved by Food and Drug administration (FDA) for treatment of COVID-19, or vaccine. Supplementation with micronutrients, such as vitamins and minerals, has gained an increasing interest as part of the supportive management of COVID-19. Vitamin C levels in serum and leukocytes are depleted during the acute stage of infection owing to increased metabolic demands. High-dose vitamin C supplement helps to normalise both serum and leukocytes vitamin C levels. Vitamin C has multiple pharmacological characteristics, antiviral, anti-oxidant, anti-inflammatory and immunomodulatory effects, which make it a potential therapeutic option in management of COVID-19. The use of high dose of intravenous vitamin C for management of COVID-19 in China and the United Stated has shown promising results. There were no reported adverse reactions with the short-term use of high dose of vitamin C. Given the fact that vitamin C is cheap, available and safe drug with beneficial effects in management of viral infections and critically ill patients reported in previous clinical trials, it is sensible to add it to COVID-19 management protocol particularly if the current ongoing clinical trials testing the effect of vitamin C in management of COVID-19 show positive results.
    MeSH term(s) Animals ; Antiviral Agents/administration & dosage ; Antiviral Agents/pharmacology ; Ascorbic Acid/administration & dosage ; Ascorbic Acid/pharmacology ; COVID-19/drug therapy ; COVID-19/virology ; Dietary Supplements ; Dose-Response Relationship, Drug ; Humans
    Chemical Substances Antiviral Agents ; Ascorbic Acid (PQ6CK8PD0R)
    Keywords covid19
    Language English
    Publishing date 2020-10-28
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2186248-5
    ISSN 1734-1140
    ISSN 1734-1140
    DOI 10.1007/s43440-020-00176-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Extrapulmonary and atypical clinical presentations of COVID-19.

    Abobaker, Anis / Raba, Ali Ahmed / Alzwi, Aboubaker

    Journal of medical virology

    2020  Volume 92, Issue 11, Page(s) 2458–2464

    Abstract: The novel coronavirus (SARS-CoV2) has led to an outbreak of multiple cases of pneumonia in Wuhan city in December 2019. The disease caused by this virus was named coronavirus disease 2019 or "COVID-19", which was declared by the World Health Organization ...

    Abstract The novel coronavirus (SARS-CoV2) has led to an outbreak of multiple cases of pneumonia in Wuhan city in December 2019. The disease caused by this virus was named coronavirus disease 2019 or "COVID-19", which was declared by the World Health Organization as a global pandemic in March 2020. It typically presents with respiratory symptoms and febrile illness. However, there are few reported extrapulmonary and atypical presentations, such as hemoptysis, cardiac, neurological, gastrointestinal, ocular, and cutaneous manifestations, as well as venous and arterial thrombosis. Lack of awareness of these presentations might lead to misdiagnosis, delayed diagnosis, and isolation of suspected patients which increases the risk of transmission of infection between patients and doctors. All these issues will be discussed in this review.
    MeSH term(s) COVID-19/complications ; COVID-19/diagnosis ; COVID-19/physiopathology ; Disease Outbreaks ; Gastrointestinal Diseases/diagnosis ; Gastrointestinal Diseases/virology ; Heart Diseases/diagnosis ; Heart Diseases/virology ; Humans ; Nervous System Diseases/diagnosis ; Nervous System Diseases/virology ; Thrombosis/diagnosis ; Thrombosis/virology
    Keywords covid19
    Language English
    Publishing date 2020-06-29
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.26157
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Overview of the possible role of vitamin C in management of COVID-19

    Abobaker, Anis / Alzwi, Aboubaker / Alraied, Alsalheen Hamed A

    Pharmacol. rep

    Abstract: The mainstay of management of coronavirus disease 2019 (COVID-19) is mainly supportive as to date there is no effective antiviral treatment, apart from remdesivir which has been approved by Food and Drug administration (FDA) for treatment of COVID-19, or ...

    Abstract The mainstay of management of coronavirus disease 2019 (COVID-19) is mainly supportive as to date there is no effective antiviral treatment, apart from remdesivir which has been approved by Food and Drug administration (FDA) for treatment of COVID-19, or vaccine. Supplementation with micronutrients, such as vitamins and minerals, has gained an increasing interest as part of the supportive management of COVID-19. Vitamin C levels in serum and leukocytes are depleted during the acute stage of infection owing to increased metabolic demands. High-dose vitamin C supplement helps to normalise both serum and leukocytes vitamin C levels. Vitamin C has multiple pharmacological characteristics, antiviral, anti-oxidant, anti-inflammatory and immunomodulatory effects, which make it a potential therapeutic option in management of COVID-19. The use of high dose of intravenous vitamin C for management of COVID-19 in China and the United Stated has shown promising results. There were no reported adverse reactions with the short-term use of high dose of vitamin C. Given the fact that vitamin C is cheap, available and safe drug with beneficial effects in management of viral infections and critically ill patients reported in previous clinical trials, it is sensible to add it to COVID-19 management protocol particularly if the current ongoing clinical trials testing the effect of vitamin C in management of COVID-19 show positive results.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #893372
    Database COVID19

    Kategorien

  8. Article: Extrapulmonary and atypical clinical presentations of COVID-19

    Abobaker, Anis / Raba, Ali Ahmed / Alzwi, Aboubaker

    J. med. virol

    Abstract: The novel coronavirus (SARS-CoV2) has led to an outbreak of multiple cases of pneumonia in Wuhan city in December 2019. The disease caused by this virus was named coronavirus disease 2019 or "COVID-19", which was declared by the World Health Organization ...

    Abstract The novel coronavirus (SARS-CoV2) has led to an outbreak of multiple cases of pneumonia in Wuhan city in December 2019. The disease caused by this virus was named coronavirus disease 2019 or "COVID-19", which was declared by the World Health Organization as a global pandemic in March 2020. It typically presents with respiratory symptoms and febrile illness. However, there are few reported extrapulmonary and atypical presentations, such as hemoptysis, cardiac, neurological, gastrointestinal, ocular, and cutaneous manifestations, as well as venous and arterial thrombosis. Lack of awareness of these presentations might lead to misdiagnosis, delayed diagnosis, and isolation of suspected patients which increases the risk of transmission of infection between patients and doctors. All these issues will be discussed in this review.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #592251
    Database COVID19

    Kategorien

To top